A Preexisting Rare PIK3CAE545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling.
about
A Preexisting Rare PIK3CAE545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A Preexisting Rare PIK3CAE545K ...... s Dependent on S6K1 Signaling.
@en
A Preexisting Rare PIK3CAE545K ...... s Dependent on S6K1 Signaling.
@nl
type
label
A Preexisting Rare PIK3CAE545K ...... s Dependent on S6K1 Signaling.
@en
A Preexisting Rare PIK3CAE545K ...... s Dependent on S6K1 Signaling.
@nl
prefLabel
A Preexisting Rare PIK3CAE545K ...... s Dependent on S6K1 Signaling.
@en
A Preexisting Rare PIK3CAE545K ...... s Dependent on S6K1 Signaling.
@nl
P2093
P2860
P50
P1433
P1476
A Preexisting Rare PIK3CAE545K ...... Is Dependent on S6K1 Signaling
@en
P2093
Andrew E Aplin
David Y Zhang
Dzifa Y Duose
Fernando C L Carapeto
Jennifer A Wargo
Jennifer L McQuade
Jessica L F Teh
Jianhua Zhang
Lawrence N Kwong
P2860
P304
P356
10.1158/2159-8290.CD-17-0745
P577
2018-03-01T00:00:00Z